Castle Biosciences Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Guidance Above Estimates.
Castle Biosciences Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Guidance Above Estimates.
Castle biosciences發佈Q2業績，營收超出預期並將FY24營業收入指引上調。公司股價因此上漲。
Castle Biosciences Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Guidance Above Estimates.
Castle biosciences發佈Q2業績，營收超出預期並將FY24營業收入指引上調。公司股價因此上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。